Ledger.Open graph →
SEC Form D · Amendment · filed April 13, 2018

Serina Therapeutics, Inc

Offering
$32.5M
Sold
$8.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HUNTSVILLE, AL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James R. Hudson, Jr · Huntsville, ALDirectorBarbara M. Fisk · Madison, ALDirectorMiguel A. Loya · Houston, TXDirectorBrendan A. Rae · Huntsville, ALExecMichael D. Bentley · Huntsville, ALExec · DirectorRandall W. Moreadith · Huntsville, ALExec · DirectorTacey R. Viegas · Madison, ALExecPatrick J. Haynes, Iii · Chicago, ILDirectorThomas J. Friedman · Chicago, ILExecJ M. Harris · Huntsville, ALExec · DirectorMichael D. Barnes · Washington, Washington, D.C.Exec · DirectorNancy C. Floyd · Washington, Washington, D.C.DirectorVincent L. Ammann · Washington, Washington, D.C.Exec · DirectorRoberta W. Sims · Washington, Washington, D.C.DirectorGeorge P. Clancy · Washington, Washington, D.C.ExecJoshua Tamaroff · NEW YORK, NYExecJeffrey Fried · Elmhurst, NYDirectorJ M. Harris · Huntsville, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗